European journal of cancer (Oxford, England : 1990) | Journament

Journal Ranking

#2800 / 33,968
📊 Below Average
Overall Score
40.3/100
Score Breakdown
Engagement
31
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
35
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
Updated 2 weeks ago

European journal of cancer (Oxford, England : 1990)

Login or register to claim ownership or editorship of this journal.
Quality Widget - Embed on Your Website

Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.

One-Line JavaScript Embed (Recommended):
Advantages:
  • ✅ Simpler integration (just one line of code)
  • ✅ Better SEO (content is in same DOM)
  • ✅ No iframe limitations
  • ✅ Fully self-contained (no dependencies)
  • ✅ Works on any website regardless of CSS framework
  • ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
  • ⚠️ Display-only (scores not clickable due to iframe constraints)
  • ⚠️ May have SEO limitations
  • ⚠️ Potential CORS/CSP issues on some websites
Preview:
Indexings
ncbi
Short Name Eur J Cancer
Abbreviated Name eur j cancer
ISSN 1879-0852
Aim and Scope
URL https://www.journals.elsevier.com/european-journal-of-cancer
Author Instructions

Publications Per Year

Recent Articles (24 total)

1996
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin
Dompeling EC;Donnelly JP;Deresinski SC;Feld R;Lane-Allman EF;De Pauw BE;;
Vol. 32A , No. 8 , pp. -
418 views Abstract
2001
Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution
Haupt R;Romanengo M;Fears T;Viscoli C;Castagnola E;;
Vol. 37 , No. 18 , pp. -
407 views Abstract
2019
Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.
Hohenberger, Peter;Bonvalot, Sylvie;van Coevorden, Frits;Rutkowski, Pjotr;Stoeckle, Eberhard;Olungu, Christine;Litiere, Saskia;Wardelmann, Eva;Gronchi, Alessandro;Casali, Paolo;
Vol. 120 , pp. 47-53
389 views DOI Abstract
2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting.
Corbaux, Pauline;Maillet, Denis;Boespflug, Amélie;Locatelli-Sanchez, Myriam;Perier-Muzet, Marie;Duruisseaux, Michaël;Kiakouama-Maleka, Lize;Dalle, Stéphane;Falandry, Claire;Péron, Julien;
Vol. 121 , pp. 192-201
384 views DOI Abstract
2019
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.
Davidson, Michael;Aronson, Lauren I;Howard-Reeves, Julie;Bryant, Hanna;Cutts, Rosalind J;Hulkki-Wilson, Sanna;Kouvelakis, Kyriakos;Kalaitzaki, Eftheleria;Watkins, David;Starling, Naureen;Rao, Sheela;Cardenosa, Marta Llorca;Begum, Ruwaida;Rana, Isma;Lazaro-Alcausi, Retchel;Terlizzo, Monica;Wotherspoon, Andrew;Brown, Gina;Swansbury, John;Lord, Christopher J;Cunningham, David;Chau, Ian;Chong, Irene Y;
Vol. 122 , pp. 12-21
376 views DOI Abstract
2020
Comment on "The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region" and reflections from the Italian Association of Oncology Nurses.
Biagioli, Valentina;Belloni, Silvia;Albanesi, Beatrice;Piredda, Alessio;Caruso, Rosario;
Vol. 135 , pp. 8-10
357 views DOI
2019
Superior skin cancer classification by the combination of human and artificial intelligence.
Hekler, Achim;Utikal, Jochen S;Enk, Alexander H;Hauschild, Axel;Weichenthal, Michael;Maron, Roman C;Berking, Carola;Haferkamp, Sebastian;Klode, Joachim;Schadendorf, Dirk;Schilling, Bastian;Holland-Letz, Tim;Izar, Benjamin;von Kalle, Christof;Fröhling, Stefan;Brinker, Titus J;, ;
Vol. 120 , pp. 114-121
346 views DOI Abstract
1993
Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours.
Olweny, C L;Juttner, C A;Rofe, P;Barrow, G;Esterman, A;Waltham, R;Abdi, E;Chesterman, H;Seshadri, R;Sage, E;
Vol. 29A , No. 6 , pp. 826-30
344 views Abstract
2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
Yang, Qi;Cao, Su-Mei;Guo, Ling;Hua, Yi-Jun;Huang, Pei-Yu;Zhang, Xiao-Long;Lin, Mei;You, Rui;Zou, Xiong;Liu, You-Ping;Xie, Yu-Long;Wang, Zhi-Qiang;Mai, Hai-Qiang;Chen, Qiu-Yan;Tang, Lin-Quan;Mo, Hao-Yuan;Cao, Ka-Jia;Qian, Chao-Nan;Zhao, Chong;Xiang, Yan-Qun;Zhang, Xiu-Ping;Lin, Zhi-Xiong;Li, Wei-Xiong;Liu, Qing;Li, Ji-Bin;Ling, Li;Guo, Xiang;Hong, Ming-Huang;Chen, Ming-Yuan;
Vol. 119 , pp. 87-96
329 views DOI Abstract
2020
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
Cafferty, Fay H;White, Jeff D;Shamash, Jonathan;Hennig, Ivo;Stenning, Sally P;Huddart, Robert A;, ;
Vol. 127 , pp. 139-149
326 views DOI Abstract
View All 24 Articles
40
Overall
Below Average
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

40.3/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.1/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

34.5/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.